{
    "title": "109_hr3955",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Meth Lab Eradication Act''.\n\nSEC. 2. TRANSFER OF EPHEDRINE, PSEUDOEPHEDRINE, AND PHENYLPROPANOLAMINE \n              TO SCHEDULE V; EXCEPTION FOR LIST I PSEUDOEPHEDRINE \n              PRODUCTS.\n\n    (a) Transfer to Schedule V; Exception.--Section 202(c) of the \nControlled Substances Act (21 U.S.C. 812(c)) is amended in schedule V--\n            (1) by inserting ``(a)'' before ``Any compound''; and\n            (2) by adding at the end the following:\n    ``(b) Unless specifically excepted or unless listed in another \nschedule, any of the following substances, including their salts, \noptical isomers, and salts of optical isomers:\n            ``(1) Ephedrine.\n            ``(2) Pseudoephedrine.\n            ``(3) Phenlypropanolamine.\n    ``(c) Pseudoephedrine, including its salts, optical isomers, and \nsalts of optical isomers, is excepted from this schedule when contained \nin a product that--\n            ``(1) is in the form of a liquid, liquid capsule, or \n        liquid-filled gel capsule;\n            ``(2) does not contain more than 360 milligrams of \n        pseudoephedrine; and\n            ``(3) is approved under section 505 of the Federal Food, \n        Drug, and Cosmetic Act.''.\n    (b) Conforming Amendments Regarding List I Chemicals.--\n            (1) Definition; striking of provisions relating to \n        ephedrine and phenylpropanolamine.--Section 102(34) of the \n        Controlled Substances Act (21 U.S.C. 802(34)) is amended--\n                    (A) by striking subparagraphs (C) and (I);\n                    (B) by redesignating subparagraphs (D) through (H) \n                as subparagraphs (C) through (G), respectively;\n                    (C) by redesignating subparagraphs (J) through (Y) \n                as subparagraphs (H) through (W), respectively; and\n                    (D) by moving subparagraphs (N), (Q), and (S) (as \n                so redesignated) two ems to the left.\n            (2) List i pseudoephedrine product.--Section 102 of the \n        Controlled Substances Act (21 U.S.C. 802) is amended--\n                    (A) in paragraph (34), by amending subparagraph (I) \n                (as redesignated by paragraph (1)(C) of this \n                subsection) to read as follows:\n            ``(I) Pseudoephedrine, and its salts, optical isomers, and \n        salts of optical isomers, when contained in a list I \n        pseudoephedrine product (as defined in paragraph (45)).'';\n                    (B) by striking paragraph (45) and inserting the \n                following:\n    ``(45) The term `list I pseudoephedrine product' means a chemical \nspecified in paragraph (34)(I) when contained in a product referred to \nin schedule V(c).''; and\n                    (C) in paragraph (46)--\n                            (i) in subparagraph (A), by striking ``or \n                        phenylpropanolamine'';\n                            (ii) by striking subparagraph (B); and\n                            (iii) by redesignating subparagraph (C) as \n                        subparagraph (B).\n            (3) Regulated transactions.--The Controlled Substances Act \n        (21 U.S.C. 801 et seq.) is amended--\n                    (A) in section 102(a)(39)(A), by amending clause \n                (iv) to read as follows:\n                    ``(iv)(I) any transaction in a listed chemical that \n                is contained in a drug that may be marketed or \n                distributed lawfully in the United States under the \n                Federal Food, Drug, and Cosmetic Act (other than a list \n                I pseudoephedrine product) unless--\n                            ``(aa) the Attorney General has determined \n                        under section 204 that the drug or group of \n                        drugs is being diverted to obtain the listed \n                        chemical for use in the illicit production of a \n                        controlled substance; and\n                            ``(bb) the quantity of the listed chemical \n                        contained in the drug included in the \n                        transaction or multiple transactions equals or \n                        exceeds the threshold established for that \n                        chemical by the Attorney General; or\n                    ``(II) any transaction in a list I pseudoephedrine \n                product by a retail distributor, unless the Attorney \n                General has determined under section 204 that the \n                product is being diverted to obtain pseudoephedrine for \n                use in the illicit production of methamphetamine; or''; \n                and\n                    (B) in section 204, by striking subsection (e).\n\nSEC. 3. REQUIREMENTS REGARDING LIST I PSEUDOEPHEDRINE PRODUCTS.\n\n    Section 310 of the Controlled Substances Act (21 U.S.C. 830) is \namended--\n            (1) in subsection (b), by striking paragraph (3); and\n            (2) by adding at the end the following subsection:\n    ``(d) List I Pseudoephedrine Products.--\n            ``(1) Requirements regarding retail sales.--Each person who \n        sells at retail a list I pseudoephedrine product shall ensure \n        that sales of such product are made in accordance with the \n        following requirements:\n                    ``(A) In offering the product for sale, the person \n                places the product such that customers do not have \n                direct access to the product before the sale is made \n                (commonly known as behind-the-counter).\n                    ``(B) The person delivers the product directly to \n                the purchaser, and not through use of the mails or any \n                private or commercial carrier.\n                    ``(C) The person does not sell such a product that \n                is in the form of a package that can be further broken \n                down or subdivided into two or more separate and \n                distinct packages.\n                    ``(D) The person does not knowingly sell to an \n                individual more than one such product during a 24-hour \n                period.\n                    ``(E) The person maintains a written list of sales \n                of such products that identifies the products, the \n                purchasers, and the dates and times of the sales (which \n                list is referred to in this paragraph as the \n                `logbook)').\n                    ``(F) The person does not sell such a product \n                unless--\n                            ``(i) the prospective purchaser--\n                                    ``(I) is 18 years of age or older;\n                                    ``(II) presents an identification \n                                card that provides a photograph and is \n                                issued by a State or the Federal \n                                Government; and\n                                    ``(III) signs the logbook and \n                                legibly prints in the logbook his or \n                                her name, address, and the date and \n                                time of the sale; and\n                            ``(ii) the person determines that the name \n                        signed and printed in the logbook corresponds \n                        to the name provided on such identification and \n                        that the date and time entered are correct.\n                    ``(G) The person maintains possession of each \n                logbook for not fewer than two years after the date of \n                the last sale entered in the logbook.\n                    ``(H) The person does not offer a promotion in \n                which, as part of a purchase transaction, such a \n                product is provided without charge.\n                    ``(I) On the premises of the location involved, the \n                person posts a clear and conspicuous notice providing \n                as follows: `Federal law prohibits the over-the-counter \n                purchase of more than one product containing \n                pseudoephedrine in a 24-hour period, and prohibits the \n                over-the-counter purchase of more than 7,500 milligrams \n                of pseudoephedrine within a 30-day period. If you make \n                an over-the-counter purchase of such a product, you are \n                required to sign a logbook that may be accessible to \n                law enforcement officers.'\n            ``(2) Authority to require certain reports.--\n                    ``(A) In general.--With respect to each person who \n                manufactures a list I pseudoephedrine product, or who \n                distributes such a product (including a sale at \n                retail), the Attorney General may by regulation require \n                the person to report to the Attorney General--\n                            ``(i) any uncommon method of payment or \n                        delivery, or any other circumstance that the \n                        person believes may indicate that the product \n                        will be used in violation of this title;\n                            ``(ii) any proposed transaction with an \n                        individual or organization whose description or \n                        other identifying characteristic the Attorney \n                        General furnishes in advance to the person; and\n                            ``(iii) any unusual or excessive loss or \n                        disappearance of supplies of the product that \n                        are under the control of the person.\n                    ``(B) Additional reports for manufacturers and \n                distributors at wholesale.--With respect to each person \n                who manufactures a list I pseudoephedrine product, or \n                who distributes such a product at wholesale, the \n                Attorney General may by regulation require the person \n                to report to the Attorney General any transaction \n                involving an extraordinary quantity of the product.\n                    ``(C) Certain regulations.--Regulations under \n                subparagraphs (A) through (C) of subsection (b)(1) \n                apply to subparagraphs (A) and (B) of this paragraph to \n                the extent that the provisions of such subparagraphs of \n                subsection (b)(1) are identical to the provisions of \n                such subparagraphs of this paragraph. Subparagraphs (A) \n                and (B) of this paragraph do not require the Secretary \n                to promulgate regulations with respect to such \n                identical provisions.\n                    ``(D) Relation to certain exemption.--Subparagraphs \n                (A) and (B) apply notwithstanding the exemption for \n                list I pseudoephedrine products under section \n                102(39)(A)(iv)(II).\n            ``(3) Removal of exception regarding status as list i \n        chemical.--\n                    ``(A) In general.--If the Attorney General \n                determines that list I pseudoephedrine products are \n                being diverted for use in the illicit production of \n                methamphetamine, the Attorney General may by regulation \n                remove the exception under schedule V(c).\n                    ``(B) Relation to section 204.--The authority \n                established for the Attorney General under subparagraph \n                (A) is in addition to the authority under section 204. \n                The Attorney General may apply such section in lieu of \n                applying subparagraph (A).''.\n\nSEC. 4. REQUIREMENTS REGARDING SCHEDULE V METHAMPHETAMINE-RELATED \n              PRODUCTS.\n\n    (a) In General.--Section 303 of the Controlled Substances Act (21 \nU.S.C. 823) is amended by adding at the end the following subsection:\n    ``(i) With respect to schedule V methamphetamine-related products \nthat do not require prescriptions, a registration under this section \nfor a pharmacy shall provide that, for the general physical location \ninvolved, the registration is subject to the condition that a sale of \nsuch a product at retail be made in accordance with the same \nrequirements as apply under subparagraphs (B) through (I) of section \n310(d)(1) for the sale at retail of list I pseudoephedrine products.''.\n    (b) Conforming Amendment.--Section 201(g)(1) of the Controlled \nSubstances Act (21 U.S.C. 811(g)(1)), as amended by section 2(b)(1) of \nPublic Law 108-358 (118 Stat. 1663), is amended--\n            (1) by striking ``titles II and III of the Comprehensive \n        Drug Abuse Prevention and Control Act (21 U.S.C. 802 et seq.)'' \n        and inserting ``this title and title III''; and\n            (2) by adding at the end the following: ``The preceding \n        sentence does not apply to controlled substances specified in \n        schedule V(b).''.\n    (c) Definitions.--Section 102 of the Controlled Substances Act (21 \nU.S.C. 802) is amended--\n            (1) by redesignating paragraph (46) (as amended by section \n        2(b)(2)(C) of this Act) as paragraph (47); and\n            (2) by inserting after paragraph (45) the following \n        paragraph:\n    ``(46)(A) The term `schedule V methamphetamine-related product' \nmeans a product that is approved under section 505 of the Federal Food, \nDrug, and Cosmetic Act and--\n    ``(i) contains ephedrine or phenylpropanolamine; or\n    ``(ii)(I) contains pseudoephedrine; and\n    ``(II) is not a list I pseudoephedrine product.\n    ``(B) The term `schedule V pseudoephedrine product' means a product \ndescribed in subparagraph (A) to which clause (ii) of such subparagraph \napplies.''.\n\nSEC. 5. ENFORCEMENT.\n\n    (a) Sales at Retail of Methamphetamine-Related Products.--\n            (1) In general.--Section 402 of the Controlled Substances \n        Act (21 U.S.C. 842) is amended--\n                    (A) in subsection (a)--\n                            (i) in paragraph (5), by inserting ``, \n                        other than section 310(d)(2)'' before the \n                        semicolon;\n                            (ii) in paragraph (10), by striking \n                        ``section 310; or'' and inserting ``section \n                        310, other than subsection (d)(2);'';\n                            (iii) in paragraph (11), by striking the \n                        period at the end and inserting a semicolon; \n                        and\n                            (iv) by inserting after paragraph (11) the \n                        following paragraphs:\n            ``(12) who is a retail distributor to knowingly or \n        negligently sell at retail a list I pseudoephedrine product in \n        violation of a requirement under section 310(d)(1), or who is a \n        manufacturer or distributor (retail or wholesale) to fail to \n        submit a report regarding such a product that is required under \n        section 310(d)(2) or regulations under such section; or\n            ``(13) who is a pharmacy or pharmacist registered under \n        section 303(f) to knowingly or negligently sell at retail a \n        schedule V methamphetamine-related product in violation of any \n        requirement under section 303(i);''; and\n                    (B) in subsection (c)(1)(B), by inserting before \n                the period the following: ``, except that this \n                subparagraph does not apply to a violation of \n                subsection (a) or (b) of section 310 with respect to a \n                list I pseudoephedrine product by a person who is not a \n                retail distributor''.\n            (2) Conforming amendments.--Section 401 of the Controlled \n        Substances Act (21 U.S.C. 841) is amended--\n                    (A) in subsection (b)(3), in the first sentence, by \n                inserting after ``shall'' the following: ``, except to \n                the extent that section 402(a)(13) applies,''; and\n                    (B) in subsection (f)--\n                            (i) in paragraph (1), by inserting after \n                        ``shall'' the following: ``, except to the \n                        extent that section 402(a)(12) applies,''; and\n                            (ii) in paragraph (2), by inserting ``, \n                        other than subsection (d)(2),'' after ``section \n                        310''.\n    (b) Restrictions on Retail Purchases of Pseudoephedrine Products; \nViolation of Logbook Requirements for Methamphetamine-Related \nProducts.--Section 404(a) of the Controlled Substances Act (21 U.S.C. \n844(a)) is amended by inserting after the second sentence the \nfollowing: ``It shall be unlawful for any person to knowingly or \nintentionally purchase at retail without a prescription more than one \nschedule V or list I pseudoephedrine product during a 24-hour period, \nor more than 7,500 milligrams of pseudoephedrine in such products \nduring a 30-day period, or to knowingly or intentionally purchase a \nschedule V methamphetamine-related product or a list I pseudoephedrine \nproduct without signing the appropriate logbook and printing \ninformation in accordance with section 310(d)(1)(F)(i)(III) or \n303(i).''.\n    (c) Controlled Substances; Unauthorized Manufacturing-Related \nPossession or Distribution of Ephedrine, Pseudoephedrine, or \nPhenylpropanolamine; Distribution in General.--Section 401 of the \nControlled Substances Act (21 U.S.C. 841) is amended--\n            (1) in subsection (b)(3) (as amended by subsection \n        (a)(2)(A) of this section), in the first sentence, by inserting \n        ``subsection (g) or'' before ``section 402(a)(13)'' ; and\n            (2) by adding at the end the following:\n    ``(g)(1) Any person who possesses a controlled substance specified \nin schedule V(b) with intent to manufacture a controlled substance \nexcept as authorized by this title, or who possesses, distributes, or \ndispenses such a substance knowing, or having reasonable cause to \nbelieve, that the substance will be used to manufacture a controlled \nsubstance except as authorized by this title, shall be sentenced in \naccordance with the same provisions as apply under subsection (c).\n    ``(2) Any person who knowingly distributes or dispenses a \ncontrolled substance specified in schedule V(b) in violation of this \ntitle shall, except to the extent that section 402(a)(13) applies, be \nfined under title 18, United States Code, or imprisoned not more than 5 \nyears, or both.''.\n\nSEC. 6. IMPORTS.\n\n    Section 1002(a) of the Controlled Substances Import and Export Act \n(21 U.S.C. 952(a)) is amended--\n            (1) in the heading for the section, by adding at the end \n        the following: ``and ephedrine, pseudoephedrine, and \n        phenylpropanolamine'';\n            (2) in the matter preceding paragraph (1), by inserting \n        ``or ephedrine, pseudoephedrine, or phenylpropanolamine,'' \n        after ``schedule III, IV, or V of title II,''; and\n            (3) in paragraph (1), by inserting ``, and of ephedrine, \n        pseudoephedrine, and phenylpropanolamine, '' after ``coca \n        leaves''."
}